Hangzhou Minsheng Healthcare Co., Ltd.

301507

CNE1000068Q3

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-23 pm EDT			5-day change	1st Jan Change
12.73 ^CNY	-1.16%		-3.56%	-22.85%

Apr. 24	Hangzhou Minsheng Healthcare Co., Ltd. Proposes Final Dividend for the Year 2023	CI
Apr. 23	Hangzhou Minsheng Healthcare Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Hangzhou Minsheng Healthcare Co., Ltd.(XSEC:301507) added to S&P Global BMI Index

March 17, 2024

Latest news about Hangzhou Minsheng Healthcare Co., Ltd.

Hangzhou Minsheng Healthcare Co., Ltd. Proposes Final Dividend for the Year 2023	Apr. 23	CI
Hangzhou Minsheng Healthcare Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 23	CI
Hangzhou Minsheng Healthcare Co., Ltd.(XSEC:301507) added to S&P Global BMI Index	Mar. 17	CI

Chart Hangzhou Minsheng Healthcare Co., Ltd.

Duration

Period

Chart Hangzhou Minsheng Healthcare Co., Ltd.

More charts

Hangzhou Minsheng Healthcare Co Ltd is a China-based company principally engaged in the research, development, production and sales of vitamin and mineral over-the-counter (OTC) medicines and health food. The Company's main products include multidimensional element pieces (21), multivitamin mineral tablets, other mineral OTC products, other vitamin mineral health food, vitamin mineral food, probiotic series health food, probiotics series food, probiotics series daily chemicals and others. The Company mainly operates its businesses in the domestic market.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
HANGZHOU MINSHENG HEALTHCARE CO., LTD.	-22.85%	627M
ELI LILLY AND COMPANY	+38.51%	727B
NOVO NORDISK A/S	+32.92%	599B
JOHNSON & JOHNSON	-6.23%	354B
MERCK & CO., INC.	+18.78%	328B
ABBVIE INC.	+1.35%	277B
ASTRAZENECA PLC	+16.00%	243B
NOVARTIS AG	+8.22%	205B
ROCHE HOLDING AG	-5.73%	203B
AMGEN INC.	+6.19%	164B